Selected A-share announcements | Leading computing power companies Dawning Information Industry and Hygon Information Technology release their interim financial results.

Focus Today 1. Peric Special Gases: The lithography gas products have obtained qualification supplier certification from Japan GIGAPHOTON Corporation Peric Special Gases (688146.SH) announced that the company's lithography gas products (Kr/Ne, Ar/Ne/Xe) have passed the qualification supplier certification from Japan GIGAPHOTON Corporation, with the certificate valid until July 23, 2030. This certification indicates that the company's products meet the requirements of the international high-end semiconductor manufacturing industry in terms of core performance indicators such as purity and stability, which helps enhance the company's market competitiveness in the field of electronic specialty gases. However, this certification itself does not constitute a direct guarantee of orders or revenue, and there is uncertainty regarding its impact on the company's future business performance. 2. Beijing Tiantan Biological Products Corporation: Subsidiary Chengdu Rongsheng Pharmaceutical obtains clinical trial summary report for injection recombinant human coagulation factor VIII for <12 age group Beijing Tiantan Biological Products Corporation (600161.SH) announced that its subsidiary Chengdu Rongsheng Pharmaceutical Co., Ltd. has completed the clinical trial for the <12 age group adaptation of the product "Injection Recombinant Human Coagulation Factor VIII" and obtained the clinical trial summary report. The drug has demonstrated good safety in the clinical application process for patients with hemophilia A in this age group, significantly reducing the frequency of bleeding in children, and improving the patients' joint health scores (HJHS scores), target joint numbers, and quality of life scores (CHO-KLAT scores). 3. Guizhou Yibai Pharmaceutical: Guizhou Provincial Drug Administration notifies the company to suspend production and sales of pediatric cough syrup Guizhou Yibai Pharmaceutical (600594.SH) announced that the company recently received a "Notice of Suspension of Production and Sales" from the Guizhou Provincial Drug Administration. During the inspection carried out by the Food and Drug Inspection Center of the National Medical Products Administration, it was found that the company had deficiencies, including some records that were not accurately filled out, and some electronic data that were not reliably recorded. After comprehensive evaluation by the National Medical Products Administration Inspection Center, it was concluded that the company did not meet the requirements. According to the regulations, the company is now informed to immediately suspend the production and sales of pediatric cough syrup after receiving the notice. The company's revenue from pediatric cough syrup for the years 2021, 2022, 2023, and 2024 were 3.42 million yuan, 4.32 million yuan, 8.38 million yuan, and 1.51 million yuan respectively, accounting for 0.10%, 0.16%, 0.30%, and 0.07% of the company's consolidated operating income for the respective periods. The suspension of production and sales of pediatric cough syrup is expected to have a relatively minor impact on the company's performance. 4. Muyuan Foods: July sales revenue of commercial pigs reached 11.639 billion yuan, a year-on-year decrease of 10.41% Muyuan Foods (002714.SZ) announced that in July 2025, the company sold 6.355 million commercial pigs, a year-on-year change of 13.02% (including the sale of 2.377 million commercial pigs to its wholly-owned subsidiary Muyuan Meat Products Co., Ltd.); the average selling price of commercial pigs was 14.30 yuan/kg, a year-on-year change of -21.86%; the sales revenue of commercial pigs reached 11.639 billion yuan, a year-on-year decrease of 10.41%. 5. Shenzhen Anche Technologies: Controlling shareholder changes to Xirui Technology, stock resumes trading Shenzhen Anche Technologies (300572.SZ) announced that Xirui Technology plans to acquire 6.43% of the company's shares held by the controlling shareholder and actual controller He Xianning (referred to as the "first tranche of target shares"). After the completion of the transfer of the first tranche of target shares, He Xianning will entrust Xirui Technology to exercise the voting rights corresponding to 13.57% of the company's shares held by him (the "equity change this time") In addition to the completion of the transfer of the first tranche of target shares, He Xianning plans to transfer his 13.57% stake in the company (referred to as the "second tranche of target shares") to Xirui Technology after the lifting of restrictions on the shares. After the implementation of this equity change, the controlling shareholder of the company will change from He Xianning to Xirui Technology, and the actual controller of the listed company will change from He Xianning to having no actual controller. The company's stock will resume trading from the morning of Wednesday, August 6, 2025. Business Performance 1. Hygon Information Technology: Net profit attributable to parent company in the first half of the year was 1.201 billion yuan, an increase of 40.78% year-on-year Hygon Information Technology disclosed its 2025 interim report, showing that the company achieved operating income of 5.464 billion yuan for the first half of the year, a year-on-year increase of 45.21%; net profit attributable to the parent company was 1.201 billion yuan, a year-on-year increase of 40.78%; and basic earnings per share were 0.52 yuan. 2. Dawning Information Industry: Net profit attributable to parent company in the first half of the year was 731 million yuan, an increase of 29.89% year-on-year Dawning Information Industry released its 2025 interim performance report, stating that the company generated total operating income of 5.854 billion yuan for the first half of the year, a year-on-year increase of 2.49%; net profit attributable to the parent company was 731 million yuan, a year-on-year increase of 29.89%; and basic earnings per share were 0.5 yuan. Buybacks & Changes in Shareholdings 1. Cisen Pharmaceutical: Shareholder plans to reduce company's shares by no more than 3% Cisen Pharmaceutical announced that shareholder Han Yanzhen, who holds more than 5% of the company's shares, plans to reduce up to 4.53 million shares through centralized bidding trading after 15 trading days from the announcement date, not exceeding 1% of the company's total share capital; and reduce up to 9.06 million shares through block trading, not exceeding 2% of the company's total share capital, with a total reduction amount not exceeding 13.58 million shares, not exceeding 3% of the company's total share capital. The reduction plan is based on the shareholder's own capital needs and will not have a significant impact on the company's governance structure and ongoing operations. 2. Shanghai Shine-Link International Logistics: Jiarong Investment plans to reduce the company's shares by no more than 2.96% Shanghai Shine-Link International Logistics announced that Jiarong Investment Co., Ltd., a shareholder holding 2.96% of the company's shares, plans to reduce up to 10.7209 million shares of the company within three months after three trading days, through the Shanghai Stock Exchange trading system centralized bidding and block trading, accounting for 2.96% of the company's total share capital. 3. Aurora Optoelectronics: Gongqingcheng Kunshun plans to reduce the company's shares by no more than 3% Aurora Optoelectronics announced that Gongqingcheng Kunshun Entrepreneurship Investment Partnership (Limited Partnership), a shareholder holding 4.96% of the company's shares, plans to reduce the company's shares by a cumulative total of no more than 82.905 million shares, accounting for no more than 3% of the company's total share capital, through centralized bidding trading and block trading from August 27th to October 17th, 2025. 4. Wuxi Chipown Micro-electronics: Controlling shareholder and chairman plan to reduce the company's shares by no more than 2% Wuxi Chipown Micro-electronics announced that the company's controlling shareholder, actual controller, chairman, and core technical personnel, Zhang Lixin, plan to reduce the company's shares by a cumulative total of no more than 2.6262 million shares during the three months after 15 trading days through centralized bidding and/or block trading, not exceeding 2% of the company's total share capital. 5. Suzhou Agioe Technologies: Shareholders plan to reduce the company's shares by no more than 4.04% Suzhou Agioe Technologies announced that cornerstone investor, Fang Guang Erqi, plans to reduce the company's shares by a total of no more than 2.6664 million shares (representing 4.04% of the total share capital) through centralized bidding and block trading. This article is reprinted from "Tencent Self-selected Stocks", GMTEight Editor: Xu Wenqiang.